Skip to main content
SpringerLink
Log in

Pediatric Glaucoma: Glaucoma Medications and Steroids

  • Chapter
  • First Online:
Pearls of Glaucoma Management

  • 1299 Accesses

Abstract

The majority of medications used for IOP-lowering in adults are not licensed for use in children. Package inserts on topical medications warn that “safety and efficacy has not been established in children.” Despite this fact, most topical drops are used in children and are safe. Definitive trials to establish their safety and efficacy are unlikely to occur due to medicolegal constraints, namely, the difficulty in establishing accurate outcome measurements, limited sample sizes, and low financial incentives to drug companies evaluating pro­ducts in the pediatric population [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wallace DK, Steinkuller PG (1998) Ocular medications in children. Clin Pediatr 37:645–652.

    Article  CAS  Google Scholar 

  2. Patton TF, Robinson JR (1976) Pediatric dosing considerations in ophthalmology. J Pediatr Ophthalmol 13:171–178.

    PubMed  CAS  Google Scholar 

  3. Shell JW (1982) Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 26:207–218.

    Article  PubMed  CAS  Google Scholar 

  4. Levy Y, Zadok D (2004) Systemic side effects of ophthalmic drops. Clin Pediatr (Phila) 43:99–101.

    Article  Google Scholar 

  5. Berlin RJ, Lee UT, Samples JR, et al (2001) Ophthalmic drops causing coma in an infant. J Pediatr 138:441–443.

    Article  PubMed  CAS  Google Scholar 

  6. Passo MS, Palmer EA, Van Buskirk EM (1984) Plasma timolol in glaucoma patients. Ophthalmology 91:1361–1363.

    PubMed  CAS  Google Scholar 

  7. Moore W, Nischal KK (2007) Pharmacologic management of glaucoma in childhood. Paediatr Drugs 9:71–79.

    Article  PubMed  Google Scholar 

  8. Ott EZ, Mills MD, Arango S, et al (2005) A randomized trial assessing dorzolamide in patient with glaucoma who are younger than 6 years. Arch Ophthalmol 123:1177–1186.

    Article  PubMed  CAS  Google Scholar 

  9. Morris S, Geh V, Nischal KK, et al (2003) Topical dorzolamide and metabolic acidosis in a neonate. Br J Ophthalmol 87:1052–1053.

    Article  PubMed  CAS  Google Scholar 

  10. Futagi Y, Otani K, Abe J (1996) Growth suppression in children receiving acetazolamide with antiepileptic drugs. Pediatr Neurol 15:323–326.

    Article  PubMed  CAS  Google Scholar 

  11. Enyedi LB, Freedman SF (2001) Safety and efficacy of brimonidine in children with glaucoma. J AAPOS 5:281–284.

    Article  PubMed  CAS  Google Scholar 

  12. Daubert GP (2006) Is brimonidine ophthalmic a safe therapy for infants? J Clin Pharm Ther 31:289–292.

    Article  PubMed  CAS  Google Scholar 

  13. Carlsen JO, Zabriskie NA, Kwon YH, et al (1999) Apparent central nervous system depression in infants after the use of topical brimonidine. Am J Ophthalmol 128:255–256.

    Article  PubMed  CAS  Google Scholar 

  14. Korsch E, Grote A, Seybold M, et al (1999) Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma. Eur J Pediatr 158:685.

    Article  PubMed  CAS  Google Scholar 

  15. Watts P, Satterfield D, Lim MK (2007) Adverse effects of apraclonidine used in the diagnosis of Horner’s syndrome in infants. J AAPOS 11:282–283.

    Article  PubMed  Google Scholar 

  16. Schmidtborn F (1998) [Systemic side-effects of latanoprost in a child with aniridia and glaucoma]. Ophthalmologe 95: 633–634.

    Article  PubMed  CAS  Google Scholar 

  17. Enyedi LB, Freedman SF, Buckley EG (1999) The effectiveness of latanoprost for the treatment of pediatric glaucoma. J AAPOS 3:33–39.

    Article  PubMed  CAS  Google Scholar 

  18. Enyedi LB, Freedman SF (2002) Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol 47: S129–S132.

    Article  Google Scholar 

  19. Armaly MF (1963) Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol 4:187–197.

    Google Scholar 

  20. Brookes JL, Khaw PT (2005) Steroid response in children. Clin Experiment Ophthalmol 33:229–230.

    Article  PubMed  Google Scholar 

  21. Lam DS, Fan DS, Ng JS, et al (2005) Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: A randomized trial. Clin Experiment Ophthalmol 33:252–258.

    Article  PubMed  Google Scholar 

  22. Lee YJ, Park CY, Woo KI (2006) Ocular hypertensive response to topical dexamethasone ointment in children. Korean J Ophthalmol 20:166–170.

    Article  PubMed  Google Scholar 

  23. Akingbehin AO (1983) Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br J Ophthalmol 67:661–663.

    Article  PubMed  CAS  Google Scholar 

  24. Fan DS, Ng JS, Lam DS (2001) A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Ophthalmology 108:1973–1977.

    Article  PubMed  CAS  Google Scholar 

  25. Khan HA, Amitava AK (2007) Topical diclofenac versus dexamethasone after strabismus surgery: A double-blind randomized clinical trial of anti-inflammatory effect and ocular hypertensive response. Indian J Ophthalmol 55: 271–275.

    Article  PubMed  Google Scholar 

  26. Biedner BZ, David R, Grudsky A, et al (1980) Intraocular pressure response to corticosteroids in children. Br J Oph­thalmol 64:430–431.

    Article  CAS  Google Scholar 

  27. Dickerson JE Jr., Steely HT Jr., English-Wright SL, et al (1998) The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. Exp Eye Res 66:731–738.

    Article  PubMed  CAS  Google Scholar 

  28. Putney LK, Brandt JD, O’Donnell ME (1997) Effects of dexamethasone on sodium-potassium-chloride cotransport in trabecular meshwork cells. Invest Ophthalmol Vis Sci 38:1229–1240.

    PubMed  CAS  Google Scholar 

  29. Lo WR, Rowlette LL, Caballero M, et al (2003) Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Invest Ophthalmol Vis Sci 44:473–485.

    Article  PubMed  Google Scholar 

  30. Reme C, d’Epinay SL (1981) Periods of development of the normal human chamber angle. Doc Ophthalmol 51:241–268.

    Article  PubMed  CAS  Google Scholar 

  31. Knepper PA, Breen M, Weinstein HG, et al (1978) Intraoc­ular pressure and glycosaminoglycan distribution in the rabbit eye: Effect of age and dexamethasone. Exp Eye Res 27:567–575.

    Article  PubMed  CAS  Google Scholar 

  32. Knepper PA, Collins JA, Frederick R (1985) Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci 26: 1093–1100.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, 100 Stein Plaza, Los Angeles, CA, 90095, USA

    JoAnn A. Giaconi

Authors
  1. JoAnn A. Giaconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Greet Coppens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thierry Zeyen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to JoAnn A. Giaconi .

Editor information

Editors and Affiliations

  1. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    JoAnn A. Giaconi

  2. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Simon K. Law

  3. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Anne L. Coleman

  4. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Joseph Caprioli

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Giaconi, J.A., Coppens, G., Zeyen, T. (2010). Pediatric Glaucoma: Glaucoma Medications and Steroids. In: Giaconi, J., Law, S., Coleman, A., Caprioli, J. (eds) Pearls of Glaucoma Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68240-0_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68240-0_51

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-68238-7

  • Online ISBN: 978-3-540-68240-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation